The effects of antioxidant supplementation on short-term mortality in sepsis patients.

BACKGROUND: The occurrence and development of sepsis are related to the excessive production of oxygen free radicals and the weakened natural clearance mechanism. Further dependable evidence is required to clarify the effectiveness of antioxidant therapy, especially its impact on short-term mortality.

OBJECTIVES: The purpose of this systematic review and meta-analysis was to evaluate the effect of common antioxidant therapy on short-term mortality in patients with sepsis.

METHODS: According to PRISMA guidelines, a systematic literature search on antioxidants in adults sepsis patients was performed on PubMed/Medline, Embase, and the Cochrane Library from the establishment of the database to November 2023. Antioxidant supplements can be a single-drug or multi-drug combination: HAT (hydrocortisone, ascorbic acid, and thiamine), ascorbic acid, thiamine, N-acetylcysteine and selenium. The primary outcome was the effect of antioxidant treatment on short-term mortality, which included 28-day mortality, in-hospital mortality, intensive care unit mortality, and 30-day mortality. Subgroup analyses of short-term mortality were used to reduce statistical heterogeneity and publication bias.

RESULTS: Sixty studies of 130,986 sepsis patients fulfilled the predefined criteria and were quantified and meta-analyzed. Antioxidant therapy reduces the risk of short-term death in sepsis patients by multivariate meta-analysis of current data, including a reduction of in-hospital mortality ( OR  = 0.81, 95% CI 0.67 to 0.99; P =  0.040) and 28-day mortality ( OR  = 0.81, 95% CI 0.69 to 0.95]; P =  0.008). Particularly in subgroup analyses, ascorbic acid treatment can reduce in-hospital mortality ( OR  = 0.66, 95% CI 0.90 to 0.98; P  = 0.006) and 28-day mortality ( OR  = 0.43, 95% CI 0.24 to 0.75; P  = 0.003). However, the meta-analysis of RCTs found that antioxidant therapy drugs, especially ascorbic acid, did substantially reduce short-term mortality( OR  = 0.78, 95% CI 0.62 to 0.98; P  = 0.030; OR  = 0.57, 95% CI 0.36 to 0.91; P  = 0.020).

CONCLUSIONS: According to current data of RCTs, antioxidant therapy, especially ascorbic acid, has a trend of improving short-term mortality in patients with sepsis, but the evidence remains to be further demonstrated.